The impact of the COVID‐19 pandemic on care delivery and quality of life in lung cancer surgery

Teteh, Dede; Barajas, Jovani; Ferrell, Betty; Zhou, Ziaoke; Erhunmwunsee, Loretta; Raz, Dan J.; Kim, Jae Y.; Sun, Virginia

doi:10.1002/jso.26902

Cited by 11 publications

(8 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Oncological patients suffered many consequences of the COVID-19 pandemic. In the initial phases of the pandemic, the accessibility to diagnostic and therapeutic pathways was impaired due to the conversion of several departments into COVID-19 units, causing disruptions to oncological screening, treatment, and surveillance [ 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 ]. Additionally, COVID-19 infection can cause serious complications in oncological patients undergoing chemotherapy or recovering from recent surgery [ 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 ].…”

Section: Introductionmentioning

confidence: 99%

Outcomes of Thoracoscopic Lobectomy after Recent COVID-19 Infection

et al. 2023

View full text Add to dashboard Cite

Background: The COVID-19 outbreak had a massive impact on lung cancer patients with the rise in the incidence and mortality of lung cancer. Methods: We evaluated whether a recent COVID-19 infection affected the outcome of patients undergoing thoracoscopic lobectomy for lung cancer using a retrospective observational mono-centric study conducted between January 2020 and August 2022. Postoperative complications and 90-day mortality were reported. We compared lung cancer patients with a recent history of COVID-19 infection prior to thoracoscopic lobectomy to those without recent COVID-19 infection. Univariable and multivariable analyses were performed. Results: One hundred and fifty-three consecutive lung cancer patients were enrolled. Of these 30 (19%), had a history of recent COVID-19 infection prior to surgery. COVID-19 was not associated with a higher complication rate or 90-day mortality. Patients with recent COVID-19 infection had more frequent pleural adhesions (p = 0.006). There were no differences between groups regarding postoperative complications, conversion, drain removal time, total drainage output, and length of hospital stay. Conclusions: COVID-19 infection did not affect the outcomes of thoracoscopic lobectomy for lung cancer. The treatment of these patients should not be delayed in case of recent COVID-19 infection and should not differ from that of the general population.

show abstract

Section: Introductionmentioning

confidence: 99%

Outcomes of Thoracoscopic Lobectomy after Recent COVID-19 Infection

et al. 2023

View full text Add to dashboard Cite

show abstract

“…In addition to bacteria, viruses have a certain role in promoting the progression of lung cancer. Alarmingly, the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2 or COVID‐19) pandemic beginning in 2019 killed approximately 6.3 million people by the end of June 2022 [30] and has had a widespread impact on global healthcare [31]. Furthermore, lung cancer patients are at a high risk for SARS‐CoV‐2 infection and related complications [32].…”

Section: The Microbiome In Lung Cancer Patientsmentioning

confidence: 99%

The microbiome in the pathogenesis of lung cancer

Miao,

Qiu

2023

APMIS

View full text Add to dashboard Cite

As one of the malignant tumors with high incidence rate and high mortality, lung cancer seriously threatens the life safety of patients. Research shows that microorganisms are closely related to lung cancer. The microbiome is symbiotic with the host and plays a vital role in the functions of the human body. Microbiota dysbiosis is correlated with development of lung cancer. However, the underlying mechanisms are poorly understood. This paper summarizes the composition characteristics of the gut–lung axis microbiome and intratumoral microbiome in patients with lung cancer. We then expound five potential carcinogenic mechanisms based on microorganisms, such as genotoxicity, metabolism, inflammation, immune response, and angiogenesis. Next, we list three high‐throughput sequencing methods, and finally looks forward to the prospect of microorganisms as novel targets for early diagnosis and treatment of lung cancer.

show abstract

“…During the transition from hospital to home, patients and families have difficulties coping with the disease due to the interruption of medical services provided by the hospital. This is a high‐risk period for patients' readmission and death, which can seriously affect their QOL (Dharmarajan et al., 2013; Saxena et al., 2022; Teteh et al., 2022).…”

Section: Introductionmentioning

confidence: 99%

Effects of transitional care interventions on quality of life in people with lung cancer: A systematic review and meta‐analysis

Liu,

Zhao,

Yin

et al. 2024

Journal of Clinical Nursing

View full text Add to dashboard Cite

AimTo identify and appraise the quality of evidence of transitional care interventions on quality of life in lung cancer patients.BackgroundQuality of life is a strong predictor of survival. The transition from hospital to home is a high‐risk period for patients' readmission and death, which seriously affect their quality of life.DesignSystematic review and meta‐analysis.MethodsThe PubMed, Embase, Cochrane Library, Web of Science and CINAHL databases were searched from inception to 22 October 2022. The primary outcome was quality of life. Statistical analysis was conducted using Review Manager 5.4, results were expressed as standard mean difference (SMD) with a 95% confidence interval (CI). The risk of bias of the included studies was assessed using the Cochrane risk of bias assessment tool. This study was complied with PRISMA guidelines and previously registered in PROSPERO (CRD42023429464).ResultsFourteen randomized controlled trials were included consisting of a total of 1700 participants, and 12 studies were included in the meta‐analysis. It was found that transitional care interventions significantly improved quality of life (SMD = 0.21, 95% CI: 0.02 to 0.40, p = .03) and helped reduce symptoms (SMD = −0.65, 95% CI: −1.13 to −0.18, p = .007) in lung cancer patients, but did not significantly reduce anxiety and depression, and the effect on self‐efficacy was unclear.ConclusionsThis study shows that transitional care interventions can improve quality of life and reduce symptoms in patients, and that primarily educational interventions based on symptom management theory appeared to be more effective. But, there was no statistically significant effect on anxiety and depression.Relevance to Clinical PracticeThis study provides references for the application of transitional care interventions in the field of lung cancer care, and encourages nurses and physicians to apply transitional care plans to facilitate patients' safe transition from hospital to home.Patient or Public ContributionNo Patient or Public Contribution.

show abstract

The impact of the COVID‐19 pandemic on care delivery and quality of life in lung cancer surgery

Cited by 11 publications

References 31 publications

Outcomes of Thoracoscopic Lobectomy after Recent COVID-19 Infection

Outcomes of Thoracoscopic Lobectomy after Recent COVID-19 Infection

The microbiome in the pathogenesis of lung cancer

Effects of transitional care interventions on quality of life in people with lung cancer: A systematic review and meta‐analysis

Contact Info

Product

Resources

About